Genomic Prediction and Kelly Ketterson

In 2016, Syngenta acquired Genomic Prediction and hired Kelly Ketterson as Chief Operating Officer. Ketterson was previously Vice President of Clinical Operations at CooperSurgical, where she helped build the company’s embryology training program and US Center of Excellence. During her time at CooperSurgical, she helped raise awareness of infertility as a disease. She also worked to establish the world’s first clinical IVF unit.

Kelly Ketterson/Education

She previously served as executive director of Althea Science and Tyho-Galileo Research Laboratories, which she joined after graduating from the Jones Institute at Eastern Virginia Medical School. Previously, she completed a Master’s degree in biomedical science from the University of Maryland. She currently serves on the Genomic Prediction Board of Directors and is a member of the Company’s Scientific Advisory Board.

Kelly Ketterson/Experience

The Genomic Prediction Team consists of scientists and engineers with diverse backgrounds in the fields of genomics, genetics, and preimplantation testing. She is the Chief Operating Officer at Genomic Prediction and has extensive experience in reproductive technologies. She is the former Executive Director of CooperSurgical’s Clinical Operations division. She holds an M.S. in biomedical science from the Jones Institute. She is also a member of the Advisory Board of the Biomedical Engineering Society.

About Genomic Prediction Team

The Genomic Prediction team is comprised of individuals with extensive experience in reproductive genomics and preimplantation genetic testing. She has served as the Chief Operating Officer at Reprogenetics, and was previously Executive Director at Althea Science. She also graduated from the Jones Institute’s Biomedical Science Master’s Program. Before joining Genomic Prediction, Ketterson worked at CooperSurgical and has since developed a successful commercial test.

She has extensive experience in reproductive genomics

She has extensive experience in reproductive genomics, including work as the Executive Director of Tyho-Galileo Research Laboratories and Althea Science. She obtained her master’s degree from the Jones Institute, a medical school in Norfolk, Virginia. In addition to her extensive experience, she has worked in biomedical research as a clinical director and executive in several startups. She also holds a Ph.D. in Genetics.

The Genomic Prediction Team includes scientists who develop and apply advanced genetic testing for commercial crops. The company’s methodology incorporates a wealth of genetic and phenotypic resources. In addition to identifying commercial traits, the team works to identify the genomic regions responsible for them. It is also involved in developing new predictive equations. For example, the company has a genome-wide DNA database. And a large amount of data is now available.

It uses Computational Methods and Mathematical Models to Analyze these Traits

The Genomic Prediction Team has expanded its work package to include genetic testing for infertility. In addition to identifying regions that underlie commercial traits, the team develops and evaluates advanced genomic breeding techniques. The project’s work is based on the genetics of commercial crops, and it includes genome-wide analyses. Further, it uses computational methods and mathematical models to analyze these traits. However, there are also limitations to the methodology used to estimate commercial traits.

The Genomic Prediction Team also includes a team of experts who have extensive experience in genetic testing for infertility. Its work includes estimation of genetic parameters and the development of advanced genomic breeding and selection techniques. It also integrates and evaluates genomic resources, including phenotypic data. Its goal is to improve the accuracy of commercial genetic testing. It is important to have a clear understanding of the genetic markers that can help with commercial fertility.

Genomic Prediction Team’s Work Package

The Genomic Prediction Team’s work package involves estimating genetic parameters, developing advanced genomic breeding and selection techniques, and implementing genetic and phenotypic resources. The team’s analysis of commercial traits will be used to develop predictive equations for each region. It will also work to develop the underlying genomic regions governing commercial traits. The aim of the whole project is to increase the accuracy of commercial fertility and IVF.

The Genomic Prediction Team’s work package includes estimation of genetic parameters and evaluation of advanced genomic selection and breeding techniques. It also incorporates genetic and phenotypic resources for infertility and pregnancy. The project’s research team will focus on identifying the regions underlying commercial traits, such as gender, race, and nutrition. Ultimately, the goal is to predict the genetic and phenotypic characteristics of the infertility process.

Similar Articles

Most Popular